国际学生入学条件
Applications are welcome from international students who hold the equivalent of a four-year bachelor's degree. To be considered for admission, undergraduate transcripts/marksheets for each year of study, including degree conferral (diploma/degree certificate) are required. All records must be translated into English and be original or copies of the original, certified/attested by an official of the school issuing that record or the Consulate/Ministry of Education of the issuing country. The Test of English as a Foreign Language (TOEFL) is required of all students for whom English is not the native language.
Undergrad transcripts
Statement of purpose
2 letters of recommendation
Resume
TOEFL/IELTS score.
Minimum Scores for full admission:
TOEFL ibt: 79
IELTS: 6.5
展开 IDP—雅思考试联合主办方
雅思考试总分
6.5
了解更多
雅思考试指南
- 雅思总分:6.5
- 托福网考总分:79
- 托福笔试总分:160
- 其他语言考试:Duolingo - 105, PTE - 58
CRICOS代码:
申请截止日期: 请与IDP顾问联系以获取详细信息。
课程简介
LIU Pharmacy - The Arnold & Marie Schwartz College of Pharmacy and Health Sciences - offers a six-year Doctor of Pharmacy (Pharm.D.) degree program to prepare students for entry-level pharmacy practice. The Doctor of Pharmacy is classified as a doctor's degree-professional practice by the U.S. Department of Education. The program consists of two years of preprofessional studies (offered through LIU Brooklyn's Richard L. Conolly College of Liberal Arts and Sciences) and four years of professional studies.<br><br>Dramatic changes taking place in the health-care system are creating many new and exciting roles for pharmacists. The pharmacist is now not only responsible for the safe and effective distribution of prescription and nonprescription medication, but is also assuming the role of pharmaceutical therapy advisor and manager, having increasingly more patient-care responsibilities.<br><br>The entry-level pharmacist is expected to participate fully in the team-based management of the patient, including the rendering of independent clinical judgments. The pharmacist must be proficient in the search for and retrieval of information from the scientific literature, utilization of complex pharmacokinetic models to determine appropriate doses, development of individualized pharmaceutical care plans, communication with patients and health professionals, documentation of pharmaceutical interventions taking into account patients' knowledge, beliefs, and behavior, pharmacoeconomic analysis of alternative pharmaceutical interventions, and justification of services billed to managed health-care organizations and other payers.
展开